Prospective rAndomized, single-blind, mulTicenter study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-eluting cOronary stenT “XiencePrime”: results of the PATRIOT trial

Prospective rAndomized, single-blind, mulTicenter study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-eluting cOronary stenT “XiencePrime”: results of the PATRIOT trial

<p><strong>Aim</strong>. This trial was aimed at comparing the efficacy and safety of sirolimus-eluting coronary stent “Calypso” (Angioline) and everolimus-eluting coronary stent “XiencePrime” (Abbott Vascular) when used for treatment of ischemic heart disease patients.<br />...

Full description

Bibliographic Details
Main Authors: A. A. Prokhorikhin, V. I. Baystrukov, I. O. Grazhdankin, D. N. Ponomarev, V. V. Verin, A. G. Osiev, V. I. Ganyukov, A. V. Protopopov, V. V. Dyomin, S. A. Abugov, A. A. Boykov, D. U. Malaev, A. M. Karaskov, E. A. Pokushalov, E. I. Kretov
Format: Article
Language:Russian
Published: Meshalkin National Medical Research Center 2017-11-01
Series:Патология кровообращения и кардиохирургия
Subjects:
коронарный стент
рандомизированное исследование
«Калипсо»
ишемическая болезнь сердца
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/505

Internet

http://journalmeshalkin.ru/index.php/heartjournal/article/view/505

Similar Items